Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity.
暂无分享,去创建一个
[1] L. Collins,et al. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium , 1997, Antimicrobial agents and chemotherapy.
[2] Alan R. Katritzky,et al. Comprehensive Heterocyclic Chemistry IV , 1996 .
[3] E. Clarke,et al. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides. , 1995, Journal of medicinal chemistry.
[4] Lester A. Mitscher,et al. The Organic Chemistry of Drug Synthesis , 1993 .
[5] S. Zanetti,et al. 2-Phenyl-6(7)-R-substituted quinoxalines N-oxides. Synthesis, structure elucidation and antimicrobial activity , 1990 .
[6] T. Nunoshiba,et al. Genotoxicity of quinoxaline 1,4-dioxide derivatives in Escherichia coli and Salmonella typhimurium. , 1989, Mutation research.
[7] M. Haddadin,et al. Oxidative elimination of nitrous acid from nitrate esters. Preparation of Mecadox , 1985 .
[8] B. Williams,et al. Synthesis and antibacterial activity of some 3-[(alkylthio)methyl]quinoxaline 1-oxide derivatives. , 1983, Journal of medicinal chemistry.
[9] E. Abushanab,et al. Quinoxaline 1,4-dioxides. Substituent effects on the reaction of benzofurazan 1-oxides with carbonyl compounds , 1975 .
[10] E. Abushanab. Quinoxaline 1,4-dioxides. Nucleophilic displacement of sulfinyl and sulfonyl groups in acid media. Novel method for the preparation of 2-haloquinoxaline 1,4-dioxides , 1973 .
[11] B. Ternai,et al. Potential antileukemic and immunosuppressive drugs. 3. Effects of homocyclic ring substitution on the in vitro drug activity of 4-nitrobenzo-2,1,3-oxadiazoles (4-nitrobenzofurazans) and their N-oxides (4-nitrobenzofuroxans). , 1972, Journal of medicinal chemistry.
[12] J. Picard,et al. Contribution to the Chemistry of Benzfuroxan and Benzfurazan Derivatives , 1954 .
[13] C. Bradsher,et al. Synthesis and Fungistatic Activity of Some 5-(1-Methyl-2-thioalkylethylidene)-rhodanines , 1954 .